SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-019318
Filing Date
2022-05-10
Accepted
2022-05-10 16:47:56
Documents
50
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q xene-10q_20220331.htm   iXBRL 10-Q 2018614
2 EX-31.1 xene-ex311_7.htm EX-31.1 22870
3 EX-31.2 xene-ex312_9.htm EX-31.2 22911
4 EX-32.1 xene-ex321_10.htm EX-32.1 12327
5 EX-32.2 xene-ex322_6.htm EX-32.2 11911
  Complete submission text file 0001564590-22-019318.txt   5221492

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA xene-20220331.xsd EX-101.SCH 39297
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xene-20220331_cal.xml EX-101.CAL 39332
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xene-20220331_def.xml EX-101.DEF 86175
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE xene-20220331_lab.xml EX-101.LAB 282796
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xene-20220331_pre.xml EX-101.PRE 200611
44 EXTRACTED XBRL INSTANCE DOCUMENT xene-10q_20220331_htm.xml XML 585524
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36687 | Film No.: 22910606
SIC: 2834 Pharmaceutical Preparations